New scan aims to map deadly protein buildup in the heart
NCT ID NCT05758493
Summary
This study is testing a new imaging tracer called Iodine-124 evuzumitide (AT-01) to see if it can create better pictures of where harmful amyloid proteins build up in the body, especially in the heart. Researchers will scan 150 patients with systemic amyloidosis using PET/MRI or PET/CT machines to see how well the tracer works and if it correlates with disease severity. The goal is to improve how doctors see and understand this complex disease, which could help guide future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oregon Health & Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.